Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra

被引:40
|
作者
Hutchinson, M [1 ]
Raff, U [1 ]
机构
[1] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA
关键词
Parkinson's disease; substantia nigra; magnetic resonance imaging;
D O I
10.1136/jnnp.67.6.815
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives-To use MRI in a novel way to image and quantify the changes occurring in the substantia nigra in Parkinson's disease. Methods-Six patients with idiopathic Parkinson's disease were compared with six age matched control subjects. The subjects were imaged using a combination of pulse sequences hypothesised to be sensitive to cell loss. Results-The images showed patterns of change in patients with Parkinson's disease. Highly significant differences between the patients and control population were found (p < 0.001). Conclusions-This methodology suggests the possibility of detecting presymptomatic disease in those judged to be at risk, and also in confirming the diagnosis in patients with early disease. Furthermore, the technique seems to hold promise as a means for staging the disease, and possibly differentiating other forms of parkinsonism.
引用
收藏
页码:815 / 818
页数:4
相关论文
共 50 条
  • [21] Transcranial sonography of the substantia nigra in patients with Parkinson's disease
    Miwa, Hideto
    Okawa, Masae
    Kajimoto, Yoshinori
    Kondo, Tomoyoshi
    JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 4) : 15 - 20
  • [22] Method for culturing postnatal substantia nigra as an in vitro model of experimental Parkinson's disease
    Smeyne, M
    Smeyne, RJ
    BRAIN RESEARCH PROTOCOLS, 2002, 9 (02): : 105 - 111
  • [23] Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study
    Safai, Apoorva
    Prasad, Shweta
    Chougule, Tanay
    Saini, Jitender
    Pal, Pramod K.
    Ingalhalikar, Madhura
    HUMAN BRAIN MAPPING, 2020, 41 (05) : 1323 - 1333
  • [24] Is hyperhomocysteinemia associated with the structural changes of the substantia nigra in Parkinson's disease? A two-year follow-up study
    Zhang, Guohua
    Zhang, Chengguo
    Wang, Yukai
    Wang, Lijuan
    Zhang, Yuhu
    Xie, Haiqun
    Lu, Jiancong
    Nie, Kun
    PARKINSONISM & RELATED DISORDERS, 2019, 60 : 46 - 50
  • [25] Distinct Progression Pattern of Susceptibility MRI in the Substantia Nigra of Parkinson's Patients
    Du, Guangwei
    Lewis, Mechelle M.
    Sica, Christopher
    He, Lu
    Connor, James R.
    Kong, Lan
    Mailman, Richard B.
    Huang, Xuemei
    MOVEMENT DISORDERS, 2018, 33 (09) : 1423 - 1431
  • [26] Evaluation of Substantia Nigra morphology in Parkinson's Disease
    celik, Nazli Durmaz
    Kula, Asli Yaman
    Toprak, Ugur
    Saylisoy, Suzan
    Topal, Aydan
    Ozkan, Serhat
    MEDICINE, 2024, 103 (12) : E37538
  • [27] Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease
    Zhou, Bing
    Yuan, Fangzhen
    He, Zhong
    Tan, Changlian
    BRAIN IMAGING AND BEHAVIOR, 2014, 8 (01) : 97 - 101
  • [28] Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease
    Sasaki, Makoto
    Shibata, Eri
    Tohyama, Koujiro
    Takahashi, Junko
    Otsuka, Kotaro
    Tsuchiya, Kuniaki
    Takahashi, Satoshi
    Ehara, Shigeru
    Terayama, Yasuo
    Sakai, Akio
    NEUROREPORT, 2006, 17 (11) : 1215 - 1218
  • [29] Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson’s disease
    Bing Zhou
    Fangzhen Yuan
    Zhong He
    Changlian Tan
    Brain Imaging and Behavior, 2014, 8 : 97 - 101
  • [30] Substantia nigra echogenicity correlated with clinical features of Parkinson's disease
    Zhou, Hai-Yan
    Sun, Qian
    Tan, Yu-Yan
    Hu, Yun-Yun
    Zhan, Wei-Wei
    Li, Dun-Hui
    Wang, Ying
    Xiao, Qin
    Liu, Jun
    Chen, Sheng-Di
    PARKINSONISM & RELATED DISORDERS, 2016, 24 : 28 - 33